New Drug to Treat “Marijuana Addiction”

The National Institute on Drug Abuse is sponsoring nationwide clinical trials to determine if an over-the-counter supplement can effectively diminish the desire to use cannabis in habitual users. If successful, the trials could lead to the first FDA-approved medication to treat alleged cases of marijuana addiction.

N-acetylcysteine (NAC) is a nutritional supplement that provides antioxidant protection, and a pharmaceutical drug used for various purposes, including to break up mucus and to counteract acetaminophen (Tylenol) overdose.

NAC is also utilized to treat various psychiatric disorders as well as dependence on nicotine, methamphetamine, and cocaine – three substances with far more discernible addictive attributes than cannabis.

In animal studies, it has been reported NAC can restore normal regulation of glutamate release, which in turn reduces compulsive drug-seeking behaviors.

NIDA is sponsoring six trials of NAC treatment across the US. Behavioral Health Services of Pickens County, South Carolina is actively seeking volunteers who currently smoke weed and are interested in either quitting cold turkey or cutting back. Behavioral Health Services will continue NAC testing throughout 2014.

The FDA approval process is expected to take two years, with widespread use of NAC to treat “pot addiction” possible by 2017.

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts
Read More

10 Illnesses Helped by Pot

The pharmaceutical industry would like everyone to believe that the key to health can be found in a…
Read More

MedMJ for PTSD Researcher Fired

After getting our hopes up that there would finally be an FDA-approved, US government-supplied, triple-blind, clinical research trial…